SLRX - Salarius Pharmaceuticals Inc
Previous close
1.72
0 0%
Share volume: 30,335
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.72
0.00
0.00%
Fundamental analysis
9%
Profitability
8%
Dept financing
3%
Liquidity
58%
Performance
0%
Performance
5 Days
-10.75%
1 Month
-49.70%
3 Months
-55.04%
6 Months
-67.98%
1 Year
-76.15%
2 Year
-95.97%
Key data
Stock price
$1.72
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.35 - $7.60
52 WEEK CHANGE
-$0.77
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: David Arthur
Region: US
Website: http://www.flex-pharma.com/
Employees: 14
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.flex-pharma.com/
Employees: 14
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
salarius is an oncology based biotechnology company developing targeted treatments for patients who need them the most.
Recent news